Eagle Health Australia | Brand
Eagle Health Australia
Phone: +61 3 8593 7378
Reviews
to load big map
22.01.2022 Eagle Health CEO: In 2017, we grew all key product categories and delivered AUD $89.2M in revenue. With AUD $34.5M cash on hand to accelerate growth, we believe our existing portfolio plus the recently launched diabetes product will deliver strong shareholder returns in the future. Please click: http://auehh.com.au/corporate-announcements/ to view more AGM information.
21.01.2022 Eagle Health Holdings Limited (ASX: EHH) (Eagle Health or Company) is pleased to announce the Company will expand its Eagle Health Education and Experience stores along the affluent East Coast of China following the success of the Company’s current four direct diabetes stores in Xiamen, China. The company’s store expansion plans will continue throughout 2018 and 2019 with the initial focus being in the home market of Fujian province. On the basis of further strong custo...mer support and ongoing refinement of the business model and roll out strategy, the Company’s broad vision is to open up to 100 stores across China. The Company believes this retail footprint would enable access to up to 570 million consumers across China. This retail strategy will also enable Eagle Health to directly sell the Eagle Health’s Hutang One pre-meal shake diabetes product, the Company’s new range of modern Traditional Chinese Medicine (TCM) products and a selected range of health products sourced in Australia. https://www.asx.com.au/asxp/20180531/pdf/43vfs1jqgzdd3t.pdf
20.01.2022 Eagle Health Holdings Limited (ASX: EHH) is pleased to announce that after approximately two years of development and regulatory approvals with Fujian Province CFDA* they will launch a new modern range of Traditional Chinese Medicine (TCM) products to be sold only in Pharmacy including Eagle Health own stores and their ~300 strong pharmacy distributor channel. Full details: https://www.asx.com.au/asxp/20180523/pdf/43v74kk718x94x.pdf
19.01.2022 Eagle Health Holdings Limited (ASX:EHH) (Eagle Health or Company) continues its multi-dimensional integration of opportunities in a deliberate strategy matrix of geographic, production and marketing opportunities. To assist in the facilitation of this plan, the Company has engaged Sydney based corporate advisory firm, Crestbridge Capital Pty Ltd (Crestbridge) to assist the Company and act as Corporate Advisors and Transaction Facilitators as EHH seeks to aggressively implem...ent the acquisition component of its growth model. Crestbridge will work with Mr. Zhang, Managing Director of Eagle Health and his corporate team to source, secure and execute value accretive merger and acquisition opportunities for the Company. Crestbridge will also work towards creating greater market awareness of EHH and recommend capital project funding options. EHH recently announced expansion plan in its Traditional Chinese Medicine(TCM) product range and offering. Integral to that announcement is the plan to source natural, reliable, high quality raw materials and establish TCM production, including Hemp, facilities from Australia. https://www.asx.com.au/asxp/20190509/pdf/444z40gqqnn139.pdf
17.01.2022 Eagle Health launches new brand Zhang Lao San Eagle Health is committed to its plan to open 100 Education and Experience stores across China. The Company believes that the 100 stores strategy will be better executed through the promotion of Zhang Lao San brand. Eagle Health will sell its own Zhang Lao San branded products through its direct stores which are also named Zhang Lao San Education and Experience Store, online platform and WeChat channel. Zhang Lao San is an exciting new brand designed to offer an additional category of products to complement the existing Eagle branded traditional health products. https://www.asx.com.au/asxp/20190110/pdf/441s7s165m8mjz.pdf
17.01.2022 As announced previously, Eagle Health is committed to its plan to open 100 Health and Experience stores across China under the Company’s new brand Zhang Lao San. The Company is pleased to inform that as at 18th January 2019, a total of 50 stores have now opened across 14 provinces in China.
16.01.2022 Eagle Health Holdings Limited is pleased to announce that it has successfully received commitments for a placement of fully paid ordinary shares (New Shares) to various eligible sophisticated and professional investors, all of whom are non-related parties, to raise AUD$1.0 million (before costs) (Placement).
16.01.2022 EAGLE HEALTH PRESENTS 50 NEW TRADITIONAL CHINESE MEDICINE PRODUCTS IN CHINA Eagle Health presented 50 new Traditional Chinese Medicine (TCM) products at New Drug Trade Fair in China Eagle Health launch follows two years of development and regulatory approvals for TCM range 53rd China New Drug Trade Fair with 4000 exhibitors and 50,000 healthcare professionals... Eagle Health also showcased experience store retail format Click to view announcement: https://www.asx.com.au/asxp/20180809/pdf/43x696hwj6p9r7.pdf
15.01.2022 EAGLE HEALTH REVIEWS & STRENGTHENS STRATEGIC DISTRIBUTION Eagle Health Board, AMKA and Omni Innovation attend Key Stakeholder Meeting Eagle Health on track for 2018-2019 growth Three new Eagle Health Education and Experience stores to open by 31 July 2018... Dedicated Eagle online platform in development to connect consumer to digital diagnostics on vital health parameters Click to view announcement: https://www.asx.com.au/asxp/20180716/pdf/43wjtv9k0bp179.pdf
14.01.2022 https://twitter.com/SkyBusiness/status/1006812294947508224
14.01.2022 https://twitter.com/SkyBusiness/status/1006812316271333378
14.01.2022 The Company has appointed Mr Gang Xu as Executive Director, Dr Brendan James De Kauwe as Non-Executive Director and Mr Henko Vos as Company Secretary. Further, the Company has appointed Mr Andrew Smith as the interim Chairman of the Board. https://www.asx.com.au/asxp/20191118/pdf/44bpg1j0gmm4v8.pdf
14.01.2022 Eagle Health Holdings Limited (ASX: EHH) (Eagle Health or Company’) is pleased to provide an operations update regarding its product procurement in Australia for Eagledon Pharmaceutical Co., Ltd, Zhang Lao San stores and Eagle Health’s traditional distributors. As announced to the ASX on 3rd July 2019, the Company continues looking at sourcing quality products and brands outside of China including Australia and South Africa, based on the Company’s market research of consum...er demand in China. Eagle Health has just signed an initial purchase order with Healthy Max Pty Ltd (Healthy Max) for the purchase of honey products. Healthy Max ’s honey brand Harden's Own Honey was established in Australia since 1976. Australian made honey products have long been popular with Chinese consumers. Eagle Health is excited to bring these honey products to its Zhang Lao San stores and expects a positive consumer demand for these products. These products will be labelled sold under the Company’s own Australian Ecological Valley brand. See more
11.01.2022 Eagle Health is audited by Grant Thornton, Australia. This is a rigorous and robust process with a team of Chinese speaking auditors based in Adelaide. The team works closely with the Company’s internal accounting team and also travels to Xiamen, China, to conduct the full year audit and half year review of Eagle Health, as required under ASX Listing Rules and the Australian Accounting Standards. Representatives from Grant Thornton attended the Company’s Annual General Meeting in Melbourne last week to address any questions. The Board of Eagle Health reaffirms its financial disclosures as previously made. https://www.asx.com.au/asxp/20180521/pdf/43v5cs0q88gw68.pdf
11.01.2022 1H 2018 Highlights Business Initial launch of Hutang-1 pre meal diabetes shake in Xiamen, China in four own stores CFDA restrictions limiting sales potential of Hutang-1 as a food product... Expansion of Eagle Health’s Education and Experience stores along the East Coast of China target to roll out 100 stores to reach 570m potential new customers Launch of 50 new Traditional Chinese Medicine (TCM) products after approximately two years of development and regulatory approvals with Fujian Province CFDA Initiated development of a dedicated Eagle Health online platform to connect the consumer, patients and family digital diagnostics on vital health parameters Corporate Expanded collaboration with AMKA of South Africa and Mr Haroon Kalla joined the Eagle Board Commenced M&A review process to identify appropriate acquisitions Half Year Financials Revenue of A$41.7m Gross profit of A$21.1m 51.0% margin Statutory EBITDA of $7.6m, EBIT of $6.9m and NPAT of $4.8m Closing cash balance of $37.3m targeted for growth and acquisition opportunities Earnings per share of 1.56 cents https://www.asx.com.au/asxp/20180912/pdf/43y7w584pvfv9w.pdf
05.01.2022 According to statistics, foreign Chinese medicine has occupied a large share of the domestic Chinese medicine market, while in the global Chinese medicine market except China, Japan has a market share of 80%, and China only accounts for 5%. (Source People’s Daily Overseas Edition.) Australian products have always been trusted by Chinese consumers because of their clean green reputation. There will also be a natural attraction towards clean, green, organic Australian grown TCM. For Eagle Health this represents a significant opportunity. https://www.asx.com.au/asxp/20190307/pdf/4438sbtj4mvm9d.pdf
05.01.2022 Eagle Health Holdings Limited (ASX: EHH)is pleased to announce that on August 9, 2018, the Company signed a collaboration agreement with Shenzhen Zhongyuan Pharmaceutical Co., Ltd. (Zhongyuan), which will see the companies collaborate on key product categories including traditional Chinese medicine (TCM), imported health products, chronic disease nutrition and meal replacement foods. Zhongyuan was established in 2001 and has developed rapidly to 93 pharmacies, including 13 di...rectly operated stores. The company has nearly 300 employees, including more than 30 licensed pharmacists. Through this collaboration Eagle Health will further increase penetration of the Guangdong province market via Zhongyuan’s sales network, which reaches more than 110 million consumers. The collaboration will also support the launch of Eagle Health’s Education and Experience stores in the Guangdong province. Eagle Health’s current seven Education and Experience stores are located in Xiamen, a city in the Fujian province, north-east of the Guangdong province. On 31 May the Company announced the strategic plans to roll out its Education and Experience stores along the east coast of China. https://www.asx.com.au/asxp/20180822/pdf/43xk7p6x7b27nh.pdf
03.01.2022 DENDROBIUM TCM GROWTH TO 13% OF FY2017 SALES CREATES A FOCUS FOR LOCAL R&D PRIORITIES Dendrobium R&D collaboration underway with Monash University, Melbourne, Australia... Eagle Health Holdings Limited (ASX: EHH) (Eagle Health or Company) is pleased to update shareholders on new product development progress of its Dendrobium (a genus of orchid) range of Traditional Chinese Medicine (TCM) following the products’ exponential growth in sales for the 2017 Financial Year (FY2017) and the Company’s Research and Development (R&D) collaboration with Monash University Food Innovation Centre. https://www.asx.com.au/asxp/20180607/pdf/43vm3b777b0hr2.pdf
02.01.2022 Eagle Health Holdings Limited (ASX: EHH) (Eagle Health or Company), a vertically integrated producer and supplier of traditional Chinese Medicine and Western nutritional products, is pleased to present its interim financial results and Appendix 4D for the half-year ended 30 June 3018 (the Half-Year). All financial results are in Australian dollars. Key points Financial Half-Year revenue of $41.7m - up 16.4% from HY2017 and 10.3% in constant currency Double digit reven...ue growth in multiple key product categories with Protein Powders and Dendrobium leading the growth Increased investment in sales & marketing to drive brand awareness Ongoing investment in plant upgrade as well as a high speed line for the diabetes product Half year gross profit of $21.1m 50.6% margin Closing cash balance of $37.3m targeted for growth and acquisition opportunities Earnings per share of 1.54 cents https://www.asx.com.au/asxp/20180828/pdf/43xrg3kkqyffc2.pdf
02.01.2022 Eagle Health Holdings is pleased to announce our upcoming Investor Call Event on Wednesday, 12th September. This event is a live teleconference where we will present our Financial Half-Year Update. Please see attached invitation to pre-register online for the English event: 09:00am AEST. http://services.choruscall.com.au/DiamondPassRegi/register
02.01.2022 https://twitter.com/SkyBusiness/status/1006812555254353921
